News

WEBTECH 3601d
Supplements that people with irritable bowel syndrome should not take
It is important to note that data suggests that people with irritable bowel syndrome may be susceptible to vitamin C ...
Medscape2d
Pandemic Surge in IBS, Chronic Idiopathic Constipation
The prevalence of irritable bowel syndrome and constipation rose significantly during the COVID-19 pandemic, highlighting the ...
Migraine Again on MSN3d
The Best Over-the-Counter Migraine Treatments for Headache Relief at Home
Learn about common-over-the-counter (OTC) treatments for migraine attacks, including acetaminophen and NSAIDs such as aspirin ...
The Government Crackdown on Off-Brand Ozempic Has Begun. Here’s What That Means for You.
New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.
Wegovy, Zepbound and the weight-loss drugs reshaping Americans
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s how that could affect patients
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
5 most common digestive issues that are on the rise in the US (and how to tackle them)
Digestive issues like IBS, GERD, constipation, IBD, and celiac disease are increasingly prevalent due to modern lifestyles, ...
A world-first clinical trial is studying exactly what works for IBS (and how)
Irritable Bowel Syndrome (commonly known as IBS) affects about 1 in 5 Australians. It's a chronic and often debilitating ...